OrbiMed announced it secured a $200 million credit facility and filed a Current Report on Form 8-K with the SEC on July 31, 2025.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
OrbiMed announced it secured a $200 million credit facility and filed a Current Report on Form 8-K with the SEC on July 31, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
OrbiMed
Investment service in New York City, New York
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Coverage
Newest first; wire copies grouped- GlobeNewswireMyriad Genetics Announces New $200 Million Credit Facility SALT LAKE CITY, July 31, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precisi